Gradient Investments’s Cavium, Inc. CAVM Stock Holding History

Gradient Investments’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,592	Closed	-$369K	–	1135
2017 Q3	$369K	Buy	+5,592	New	+$354K	0.02%	190

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Gradient Investments's CAVM Position: Q4 2017 in Review

Gradient Investments sold out of Cavium, Inc. (CAVM) in Q4 2017, closing a stake of 5,592 shares — an estimated $369K sold.

Gradient Investments first reported a position in CAVM in Q3 2017 and held it in 1 quarter. The position peaked at $369K in Q3 2017. 264 funds tracked by Wall St. Rank hold CAVM as of Q4 2017.

Gradient Investments reported no remaining Cavium, Inc. position as of Q4 2017 after selling out during the quarter.
Gradient Investments sold 5,592 Cavium, Inc. shares in Q4 2017, an estimated $369K.
Gradient Investments first reported a position in Cavium, Inc. in Q3 2017 and held it in 1 quarter.
Gradient Investments's Cavium, Inc. position peaked at $369K in Q3 2017.
264 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2017.

Based on Gradient Investments's 13F filing for Q4 2017, filed 7 Feb 2018.